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Summary 
A number of different intracellular signaling pathways 
have been shown to be activated by receptor tyrosine 
kinases. These activation events include the phospho- 
inositide 3-kinase, 70 kDa S6 kinase, mitogen-acti- 
vated protein kinase (MAPK), phospholipase C-y, and 
the Jak/STAT pathways. The precise role of each of 
these pathways in cell signaling remains to be re- 
solved, but studies on the differentiation of mamma- 
lian PC12 cells in tissue culture and the genetics of cell 
fate determination in Drosophila and Caenorhabiditis 
suggest that the extracellular signal-regulated kinase 
(ERK-regulated) MAPK pathway may be sufficient for 
these cellular responses. Experiments with PC12 cells 
also suggest that the duration of ERK activation is criti- 
cal for cell signaling decisions, 
Introduction 
Receptor tyrosine kinases are involved in signaling both 
cell proliferation and differentiation (reviewed by Schles- 
singer and UIIrich 1992). Their rote in determining cell dif- 
ferentiation rather than proliferation is especially well ex- 
emplified from genetic studies in Caenorhabditis elegans 
and Drosophila melanogaster, in which signaling from the 
Let-23, sevenless, and torso receptors determines cell fate 
in the absence of proliferation (reviewed by Perrimon, 
1993; Dickson and Hafen, 1994). For mammalian cells in 
tissue culture, the stimulation of quiescent fibroblasts into 
DNA synthesis and the differentiation of the PC12 chro- 
maffin cell line into sympathetic neurones (Greene and 
Tischler, 1976) have been much-used experimental sys- 
tems to investigate receptor tyrosine kinase signaling. A 
central issue in attempting to understand receptor tyrosine 
kinase signaling is whether different receptors activate 
different signal transduction pathways and whether there 
are distinct pathways for differentiation and proliferation. 
Numerous studies show that, depending on where it is 
expressed, the same receptor can signal proliferation or 
differentiation; for example, the fibroblast growth factor 
receptor signals differentiation i PC12 neuronal cells but 
in fibroblasts timulates proliferation. Such observations 
indicate the critical importance of cell context in under- 
standing signaling. 
Extensive work has now elucidated the principles of sig- 
nal transduction pathways from receptor tyrosine kinases. 
Following ligand binding, receptor dimerization, and auto- 
phosphorylation, Src homology 2 (SH2) domain-con- 
taining proteins are recruited to phosphorylated tyrosine 
residues on the receptor. These SH2 domain-containing 
proteins include the p85 components of the phosphoinosi- 
tide 3-kinase (PI3-kinase) pathway; phospholipase C-7 in 
the protein kinase C pathway; Src family kinases; and 
p120-GAP, Shc, and Grb2 in the Ras pathway (reviewed 
by Schlessinger, 1994). In addition, receptor kinases are 
able to activate the p91STAT pathway (Fu and Zhang, 
1993; Silvennoinen et al., 1993; Sadowski et al., 1993). 
Recruitment o phosphorylated tyrosine residues on re- 
ceptors leads to activation of the signaling molecule by a 
variety of mechanisms: tyrosine phosphorylation in the 
case of phospholipase C-'y and STATs (Sadowski et al., 
1993); conformational changes induced by binding of the 
SH2 domain to phosphotyrosine for PI3-kinases (Backer 
et al., 1992; Carpenter et al., 1993) and SH-PTP2 tyrosine 
phosphatase (Lechleider et al., 1993); and translocation 
to the plasma membrane for stimulation of Ras guanine 
nucleotide exchange by Sos (Quilliam et al., 1994; Aron- 
helm et al., 1994). 
Attempts to Determine Critical Signaling Events 
The issue regarding which of these signaling components 
are needed for cell proliferation or differentiation has been 
a much-studied area. Numerous attempts have been 
made to delineate the importance of a particular signaling 
component or receptor phosphotyrosine by constructing 
mutant receptors that lack individual tyrosine residues and 
therefore cannot recruit SH2-containing proteins to those 
sites. With a few exceptions, e.g., Coughlin et al. (1969), 
experiments with mutant receptors tend to show that dele- 
tion of any one single site does not compromise the stimu- 
lation of DNA synthesis. Such results suggest that there 
are either parallel signal transduction pathways, each of 
which can signal DNA synthesis, or that there is redun- 
dancy in signaling. One example of redundancy is clearly 
exemplified by the experiments of Vatius and Kazlauskas 
(1993), which showed that either of two tyrosine phosphor- 
ylation sites in the platelet-derived growth factor receptor 
is sufficient for activation of p21Ra~ and stimulation of DNA 
synthesis. What is more difficult to conclude from such 
experiments is whether a known SH2-containing protein 
recruited to a particular site is essential to signaling since 
it is always possible to argue that there is another unknown 
protein recruited to the same site that is the critical signal- 
ing intermediate. 
A different way to approach the question of critical sig- 
naling pathways comes from genetic studies. Strikingly 
for the Let-23, sevenless, and torso signaling pathways, 
defects in ligand or receptor can be compensated for by 
gain-of-function alleles of Ras (Fortini et al., 1992), Raf 
(Dickson et al., 1992; Han et al., 1994), MEK (Tsuda et 
al., 1993), or extracellular signal-regulated kinase (ERK) 
(Brunner et al., 1994b), all of which lie in the same signaling 
pathway (see below). Such results are perhaps not so sur- 
prising with Ras or Raf for which it has been known for 
some time that oncogenic forms can liberate signal trans- 
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Figure 1. MAPK Pathways in Mammalian 
Cells 
Both the receptor tyrosine kinase pathways 
and the stress response pathways contain a 
central core of a serine/threonine kinase, 
MAPKKK; a dual-specificity kinase, MAPKK; 
and a serine/threonine kinase, MAPK. Recep- 
tor tyrosine kinase signaling ocurrs through 
p21Ra', and there is evidence that some stress 
responses, e.g., to ultraviolet radiation (UV), 
may also involve p21 ~a' (Hibi et al., 1993). Al- 
though MEKK-1 activation appears to be Ras- 
dependent (Lange-Carter and Johnson, 1994), 
there is no evidence yet for a direct interaction 
between Ras and MEKK-1. 
Note also that not all stimuli leading to Raf 
activation may be mediated by Ras (Howe et 
al., 1992; Fabian et al., 1994). 
Abbreviations: JNK, Jun kinase; MAPKAPK2, 
MAPK-activated protein kinase 2; PBS2, a 
dual-specificity protein kinase in the S. cerevis- 
iae osmotic regulation pathway; PO4, phos- 
phate group; SAPks, stress-activated protein 
kinases; and SEK1, appears to be a dual- 
specificity protein kinase (MAPKK), which acti- 
vates the J N Ks/SAPKs (Sanchez et al., 1994). 
duction from extracellular signals. Injection of oncogenic 
Ras into quiescent fibroblasts stimulates DNA synthesis 
in the absence of mitogenic growth factors (Ferasmisco 
et al., 1984; Morris et al., 1989). Oncogenic Ras and Raf 
will also mimic the effect of nerve growth factor (NGF) in 
stimulating neurite outgrowth in PC12 cells (Bar-Sagi and 
Ferasmico, 1985; Noda et al., 1985; Wood et al., 1993). 
It now appears that Ras may have at least two effectors, 
Raf and PI3-kinase (Rodriguez-Viciana et al., 1994), and 
activated Ras would therefore be expected to be able to 
exert a multiplicity ofeffects. However, it is more surprising 
that gain-of-function mutants of MEK and ERK overcome 
receptor defects since they lie on a single signal transduc- 
tion pathway downstream of Ras and Raf and would be 
expected to have more restricted effects. The conclusion 
that activation of the ERK pathway is sufficient is strength- 
ened by the finding that expression of constitutively acti- 
vated forms of MEK, generated by site-directed mutagene- 
sis, induces mitogenesis and transformation i  fibroblasts 
as well as differentiation ofPC12 cells (Cowley et al., 1994; 
Mansour et al., 1994). 
These results focus attention on the activation of the 
ERK family of mitogen-activated protein kinases (MAPKs) 
as a critical event in signal transduction from receptor tyro- 
sine kinases. We will therefore consider some of the as- 
pects of the control of this pathway and a model for how 
both differentiation and proliferation can be signaled by 
activation of this pathway. 
The Ras/Raf/MEK/ERK Pathway 
In the RaslRaflMEWERK pathway, a small guanine nucle- 
otide-binding protein links receptor tyrosine kinase activa- 
tion to a cytosolic protein kinase cascade. Central to the 
activation of this pathway is the activation of Ras to the 
GTP form through the promotion of guanine nucleotide 
exchange on Ras. This occurs through the complex of the 
exchange factor Sos and the adaptor protein Grb2 being 
recruited to tyrosine-phosphorylated receptors or through 
Shc-Grb2-Sos complexes (reviewed by Schlessinger, 
1994). 
The Ras/Raf/M EK/ERK pathway is one example of what 
are generically termed "MAPK" pathways. MAPK path- 
ways have as their "core" a three-component protein ki- 
nase cascade consisting of a serinelthreonine protein ki- 
nase (MAPKKK), which phosphorylates and activates a 
dual-specificity protein kinase (MAPKK), which in turn 
phosphorylates and activates another serinelthreonine 
protein kinase (MAPK) (Figure 1). In the Ras/Raf/MEK/ 
ERK pathway, Raf corresponds to MAPKKK, MEK corre- 
sponds to MAPKK, and ERK corresponds to MAPK. These 
pathways serve to link signals from the cell surface to 
cytoplasmic and nuclear events. In addition to the receptor 
tyrosine kinase-coupled Ras/Raf/MEK/ERK pathway, 
MAPK pathways mediate cell shape, osmotic integrity, 
and pheromone responses in yeasts (reviewed by Am- 
merer, 1994; Herskowitz, 1995 [this issue of Ceil]), stress 
responses in mammalian cells (Han et al., 1994; Galcheva- 
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Gargova et al., 1994; Rouse et al., 1994), and cytokine 
signaling (Freshney et al., 1994) as well as the receptor 
tyrosine kinase-coupled Ras/Raf/MEK/ERK pathway. It is 
now emerging that there is a second MAPK pathway in 
mammalian cells that involves p21Ras; this pathway medi- 
ates some of the signals that result in the N-terminal phos- 
phorylation of Jun (Figure 1). It involves Ras, MEKK-1, a 
dual-specificity kinase (SEK1), and the MAPK Jun kinase 
(JNKs/SAPKs) (Hibi et al., 1993; Minden et al., 1994; San- 
chez et al., 1994; Yan et al., 1994). 
As far as is known at present from experimental data 
and sequence comparisons, the mechanisms of activation 
of the MAPKKs and MAPKs are likely to be identical or 
very similar in all MAPK pathways. Activation of MEK has 
been shown to result from phosphorylation by Raf of two 
serine residues that are four amino acids apart in kinase 
subdomain VIII (Alessi et al., 1994; Zheng and Guan, 
1994). Two identically positioned serine residues or serine 
and threonine residues within a consensus motif, LID/ 
NSXANS/T, are found in all members of the MAPKK family 
thus far sequenced (for a recent compilation of MAPKK 
sequences, see Banuett and Herskowitz, 1994). Substitu- 
tion of the serine or threonine residues in this consensus 
with acidic amino acids to mimic phosphorylation leads 
to partial activation in MEK (Alessi et al., 1994; Mansour 
et al., 1994). The conservation of the putative phosphoryla- 
tion sites means that it is very likely that all dual-specificity 
MAPKKs are regulated in the same way and that their 
activation can be mimicked by substituting negatively 
charged amino acids at these sites. All MAPKs contain a 
TXY motif in kinase subdomain VIII, the phosphorylation 
of which on threonine and tyrosine is essential for activity. 
While identical phosphorylation events are likely to be 
responsible for the activation of MAPKKs and MAPKs, 
there appear to be multiple mechanisms for regulating 
MAPKKKs. For the Schizosaccharomyces pombe phero- 
mone response pathway, there is an obligate requirement 
for direct interaction between active RasGTP and MAPKKK/ 
byr2 (Van Aelst et al., 1993). However, in the Saccharo- 
myces cerevisiae pheromone MAPK pathways, there does 
not appear to be a role for Ras in activating MAPKKK/ 
STE11; instead, a kinase STE20 is involved (Leberer et 
al., 1992). Similarly, in the S. cerevisiae cell wall pathway, 
the MAPKKK/BCK1 is activated by a protein kinase C ho- 
molog, PKC1 (Lee et al., 1993). 
The activation of Raf by receptor tyrosine kinases re- 
quires p21Ras. Recent work demonstrates that the role of 
Ras is to recruit Raf to the plasma membrane (Leevers 
et al., 1994; Stokoe et al., 1994), where another tyrosine 
kinase-generated signal fully activates the membrane- 
bound Raf (Williams et al., 1992; Leevers et al., 1994; 
Fabian et al., 1994). Thus, tyrosine kinases generate two 
signals that interact o activate Raf; one signal is the forma- 
tion of RasGTP, while the other is unknown. Why two sig- 
nals should be required to fully activate Raf is a puzzle, 
but one rationalization isthat two signals are used because 
Ras has multiple effectors. It is now clear that Ras is re- 
quired for the Raf/Mek/ERK pathway, for PI3-kinase acti- 
vation (Rodriguez-Viciana et al., 1994), and for a MAPK 
pathway involving MEKK-1 and the Jun kinases (Lange- 
Carter and Johnson, 1994; Minden et al., 1994). The sec- 
ond signal would then be needed to acheive specificity, 
otherwise every signal that activates Ras would activate 
all effector pathways. 
Although there is much still to learn about the roles of 
each component in MAPK pathways, at the present time 
it seems that MAPK is essentially the effector of each path- 
way. The role of MAPKKK may be solely to phosphorylate 
and activate MAPKK, and the only role of MAPKK is to 
phosphorylate and activate MAPK. However, MAPK may 
have multiple substrates and therefore can set in motion 
a very wide range of events. In the case of the Ras/Raf/ 
MEK/ERK pathway, the substrates of ERK1 and ERK2 
include transcription factors and other kinases (reviewed 
by Blenis, 1993; Treisman, 1994; Hill and Treisman, 1995 
[this issue of Cell]). Genetic evidence from D. melanogas- 
ter strongly suggests that transcription factors are the tar- 
gets of receptor tyrosine kinase-mediated activation of 
ERKs. Phosphorylation of these transcription factors may 
relieve an inhibitory effect in the case of yan (Lai and Ru- 
bin, 1992) or lead to activation in the case of pointed (Brun- 
ner et al., 1994a). 
In PC12 Cells, Cellular Responses Are Determined 
by the Duration of ERK Activation 
The response of PC12 cells to receptor tyrosine kinase 
activation has been extensively used as an experimental 
system to study signal transduction and how activation of 
some receptors leads to differentiation while the activation 
of others leads to proliferation. Treatment of PC12 cells 
with fibroblast growth factor or NGF leads to outgrowth 
of neurites and eventual cessation of celt division (Greene 
and Tischler, 1976), whereas treatment with epidermal 
growth factor (EGF) leads to a proliferative signal (Huff et 
al., 1981). An expectation of these studies was the identifi- 
cation of differentiation-specific pathways. One example 
has been found in the NGF, but not the EGF, stimulation 
of tyrosine phosphorylation of an 80 kDa protein, SNT 
(Rabin et al., 1993). At the qualitative level, many signal 
transduction events seem to be shared between differenti- 
ation and proliferation in PC12 cells (Chao, 1992). How- 
ever, notable quantitative differences are found between 
differentiation and proliferative signals. NGF stimulation 
results in a persistent elevation of RasGTP, whereas EGF 
produces only a short-lived rise in RasGTP (Muroya et 
al., 1992). ERK (MAPK) activation is sustained for several 
hours following NGF stimulation, but it is short lived after 
EGF stimulation (Heasley and Johnson, 1992; Traverse 
et al., 1992; Nguyen et al., 1993). In part, these differences 
may reflect the differences in receptor down-regulation of 
the EGF receptor and TrkA. Another difference between 
the two pathways is that EGF and NGF utilize different 
signal transduction pathways to stimulate RasGTP: the 
Grb2-Sos complex is directly bound to the EGF receptor, 
whereas TrkA stimulates Shc phosphorylation and the for- 
mation of Shc-Grb2-Sos complexes without direct bind- 
ing of Grb2-Sos to TrkA (Buday and Downward, 1993; 
Obermeier et al., 1994; Stephens et al., 1994). 
The association of prolonged ERK activation with NGF 
stimulation of PC12 cells has led to the idea that it is sus- 
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tained activation of this pathway that leads to differentia- 
tion. This is consistent with the findings that both onco- 
genic Ras and oncogenic Raf can stimulate neurite 
outgrowth (Noda et al., 1985; Wood et al., 1993), since 
both of these oncoproteins would be expected to produce 
prolonged activation of ERKs (Leevers and Marshall, 
1992). Two different types of experiments lend support 
to the idea that there is no receptor-specific pathway of 
differentiation and that sustained activation of ERKs is 
sufficient for PC12 differentiation. In the first set of experi- 
ments, the effects of heterologous expression of receptors 
and alterations in endogenous receptor number have been 
examined. PC12 cells do not express the platelet-derived 
growth factor receptor, but transfection of platelet-derived 
growth factor receptor constructs leads to PDGF-depen- 
dent differentiation and sustained activation of ERKs 
(Heasley and Johnson, 1992). The endogenous insulin 
receptor of PC12 cells does not trigger RasGTP loading, 
ERK activation, or differentiation (Ohmichi et al., 1993); 
however, if it is overexpressed, ERK is activated and differ- 
entiation results (Dikic et al., 1994). While stimulation of 
the endogenous EGF receptor does not lead to differentia- 
tion, overexpression leads to EGF-dependent differentia- 
tion and sustained activation of ERKs (Traverse et al., 
1994). Since the EGF receptor is more rapidly down- 
regulated than the NGF receptor through internalization 
and phosphorylation (Countaway et al., 1992), these re- 
sults suggest that it is the number of active cell surface 
receptors that determines whether ERK activation is sus- 
tained and differentiation results. An important corollary 
to receptor overexpression experiments comes from the 
converse approach. PC12 cell lines have been selected 
that do not respond to NGF as a differentiation signal. In 
these cells, the number of TrkA-NGF receptor molecules 
per cell is reduced, ERK activation is transient, and the 
response to NGF is proliferation (Schlessinger and Bar- 
Sagi, 1995). In every situation examined thus far, manipu- 
lating receptor numbers to produce differentation corre- 
lates with sustained activation of ERKs, whereas transient 
activation is not associated with differentiation. 
The second set of experiments suggesting that ERK 
activation is the key event in PC12 differentiation is the 
introduction of MEK mutants. Appropriate mutations in the 
phosphorylation sites of MEK1 that are the sites of activa- 
tion by Raf lead to activating and interfering mutants. The 
interfering mutants block ligand activation of ERK and 
block differentiation of PC12 cells, whereas the activating 
mutants induce neurite outgrowth in the absence of differ- 
entiating factors (Cowley et al., 1994). The effect of the 
activated MEK is direct rather than through the induction of 
growth factors that act back through cell surface receptors 
because induction of differentiation by activated MEK is 
not blocked by microinjection of Ras neutralizing antibod- 
ies, which block ligand-activated ifferentiation. 
A Model 
A model based on these experiments is one that shows 
cells can enact differentiation or proliferative responses 
to receptor tyrosine kinases purely on the basis of the 
duration of ERK activation. An attractive rationalization for 
1 hr 2hr ~ 
ERK ~ O Nuclear ERKs phosphorylate 
activity transcription factors leading to 
new gene expression for 
lhr  2hr differentiation to sympathetic 
neurones 
Figure 2. Sustained Activation Leads to Translocation of ERKs and 
the Induction of New Gene Expression 
The relative amount of ERK in the cytoplasm and the nucleus is indi- 
cated by the level of stippling. 
the manner by which sustained activation of ERKs can 
lead to a different cellular response than transient activa- 
tion rests on the observation that ERKs can translocate 
to the nucleus upon activation (Chen et al., 1992). In every 
case examined thus far in PC12 cells, sustained ERK acti- 
vation is associated with translocation of ERKs to the nu- 
cleus (Traverse et al., 1992, 1994; Nguyen et al., 1993; 
Dikic et al., 1994), whereas transient activation does not 
lead to nuclear translocation. Transient activation will 
therefore have very different consequences for gene ex- 
pression compared with sustained activation because nu- 
clear accumulation of active ERK will result in phosphory- 
lation of transcription factors (Figure 2). In this way, the 
quantitative difference in ERK activation is translated into 
a qualitative difference in transcription factor activation. 
Implicit in this model is the idea that the cellular response 
is determined by which transcription factors are present 
in the cell. Thus, the activation of the receptor tyrosine 
kinase and the subsequent activation of ERKs is just the 
final switch that seals a fate determined by previous devel- 
opmental events that set which ERK-responsive transcrip- 
tion factors are present in the cell. It is not a requirement 
of this model that sustained activation of ERKs invariably 
leads to differentiation, whereas transient activation al- 
ways leads to proliferation. In other cell types, the con- 
verse may be true: it is clear that in fibroblasts, sustained 
activation of ERKs is associated with proliferation, not dif- 
ferentiation (Meloche et al., 1992; Mansour et al., 1994; 
Cowley et al., 1994). The important feature of the model 
is that cells can use transient and sustained activation of 
ERKs to determine different responses. 
The idea of sustained versus transient ERK activation 
being critical for changes in gene expression can be 
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readily extended to threshold effects in development, in 
which small changes in ligand concentration resulting from 
developmental gradients produce qualitative differences 
in gene expression (Green et al., 1992). Small differences 
in ligand concentration could lead to sustained versus 
transient ERK activation and thereby could lead to nuclear 
translocation to alter gene expression (Dikic et al., 1994; 
Traverse et al., 1994). 
There are potentially many different ways for receptors 
to signal transient versus sustained ERK activation. It has 
already been demonstrated that differences in receptor 
number markedly affect the duration of ERK activation. 
As discussed above, small changes in ligand concentra- 
tion may have similar effects. The rate of internalization 
of receptors and whether they are down-regulated as a 
result of activation of the Ras/Raf/MEK/ERK pathway may 
also affect the duration of signaling. The EGF receptor 
may be more rapidly internalized than the NGF receptor 
and is subject to down-regulation through phosphorylation 
(Countway et al., 1992). In addition, different levels and 
kinetics of ERK activation could be generated by differen- 
tial usage of signaling pathways downstream of receptors. 
The activation of Ras has multiple pathways, including 
direct receptor-Grb2-Sos complexes (Buday and Down- 
ward, 1993), receptor-Syp-Grb2-Sos complexes (Li et al., 
1994), and Shc-Grb2-Sos complexes (Obermeier et al., 
1994; Stephens et al., 1994). There may also be Ras- 
(Burgering et al., 1993; Howe et al., 1992) and Raf- 
independent (Lange-Carter and Johnson, 1994) routes to 
ERK activation. Each of these different signaling pathways 
could have different consequences for the level and dura- 
tion of ERK activation and could be selectively used by 
different receptors to regulate the amplitude and duration 
of signaling. 
A serious limitation in applying this model to other sys- 
tems is that it is based wholly on experiments with PC12 
cells. It is conceivable that these cells may represent a 
very abnormal system and that, in other cell types, there 
are qualitative differences in signaling events for prolifera- 
tion versus differentiation. However, it is clear from studies 
in both C. elegans and D. melanogaster that the same 
components of receptor tyrosine kinase signaling that are 
involved in the decisions about cell fate are also involved 
in proliferation since defects in Ras, Raf, MEK, or ERK 
lead to reduced cell proliferation in embryos and are lethal 
(Dickson and Hafen, 1994; Tsuda et al., 1993; Perrimon, 
1993). 
Conclusions 
The arguments put forward here propose that when cells 
make decisions about proliferation versus differentiation 
through receptor tyrosine kinase signaling, they do it by 
differences in the duration of ERK activation. Such consid- 
erations highlight the importance in development of re- 
stricted expression of receptors and especially their li- 
gands (reviewed by Jessell and Melton, 1992). If the 
presence of growth factors and receptors was not limited 
in time and space, the activation of a pathway common 
to all receptor tyrosine kinases would be disastrous. In 
addition, prior developmental events limit which cells re- 
spond to ligand. At one level, this restriction could operate 
by limiting in which cells a transcription factor is ex- 
pressed, but restrictions must also operate at other levels. 
In the D. melanogaster eye, only the R7 cells respond to 
activation of the sevenless receptor by the bride of sev- 
enless ligand expressed on the R8 cell even though sur- 
rounding cells express the receptor and contact the ligand. 
Exactly where this restriction operates within the Ras/Raf/ 
MEK/ERK pathway is an intriguing issue. 
In the model presented here, receptor tyrosine kinases 
work in development as switches to complete a develop- 
mental program determined by previous developmental 
events. This means that the outcome of receptor tyrosine 
kinase signaling depends both on the duration of ERK 
activation and cell context. A critical aspect of cell context 
will be which ERK-responsive transcription factors are 
present. 
This review has heavily emphasized the role of those 
receptor tyrosine kinase signaling events that result in 
ERK activation; the question then remains whether other 
signaling events contribute to differentiation or prolifera- 
tion. For example, PI3-kinase activation by recruitment of 
p85 subunits to either the NGF receptor or the fibroblast 
growth factor receptor is not necessary for the differentia- 
tion response of PC12 cells and does not appear to affect 
ERK activation (Obermeier et al., 1994; Spivak-Kroizman 
et al., 1994). Signaling events that do not regulate ERK 
activation may mediate aspects of tyrosine kinase signal- 
ing such as ligand-stimulated cell survival, cytoskeletal 
rearrangements, cell migration, and chemotaxis (Ridley 
et al., 1992; Ridley and Hall, 1992). This is illustrated by 
the finding that activation of protein kinase C by the c-Kit 
receptor appears to promote cell motility rather than mito- 
genesis (Blume-Jensen et al., 1993). It is possible that 
much of the specificity in receptor signaling is for purposes 
other than controlling proliferation and differentiation. 
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